pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 14·1 min read
save

Drugmakers have to go through rigorous tests to get a lower tariff rate

Landing a reduced 20% tariff rate will require pharma companies to fill out extensive paperwork and be closely monitored by the Department of Commerce. President Donald Trump signed an executive order last ...

May 14, 2026·read at Endpoints ↗

May 14, 2026 12:00 PM EDT PharmaManufacturing Drug­mak­ers have to go through rig­or­ous tests to get a low­er tar­iff rate Anna Brown News Reporter Land­ing a re­duced 20% tar­iff rate will re­quire phar­ma com­pa­nies to fill out ex­ten­sive pa­per­work and be close­ly mon­i­tored by the De­part­ment of Com­merce. Pres­i­dent … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
84 words · retrieved May 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 8h agoMerck's top dealmaker signals more M&A as Keytruda's patent cliff nearsEndpoints
  • 11h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 12h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 12h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 13h agoHealth tech investors are looking at bigger betsEndpoints